The National Commission for Women (NCW) in India recently acted to address growing irregularities in the rapidly expanding fertility sector. Specifically, the commission established a high-level expert panel to carry out a comprehensive review of the laws governing reproductive medicine. This newly formed committee will focus heavily on IVF clinic regulation, ensuring the safety, dignity, and reproductive rights of women. Ultimately, this review aims to strengthen institutional accountability and standardise clinical environments for assisted reproductive technologies (ART) nationwide.

The Immediate Drivers of IVF Clinic Regulation Reform

The rapid expansion of the assisted reproductive technology sector in India has brought numerous ethical and legal challenges. Recently, a severe IVF fraud case in Gurugram triggered widespread public outrage and intense media scrutiny. In this specific case, DNA tests revealed that the twins born to a couple were not biologically related to them. Consequently, this shocking baby mix-up exposed glaring deficiencies in clinical verification and biological traceability protocols. For this reason, the NCW intervened to address these systemic vulnerabilities. Although registration under the National ART and Surrogacy Registry remains mandatory, regulatory compliance alone has failed to prevent unethical practices. Furthermore, many facilities operate with highly inconsistent treatment standards and inadequate quality control. Patients frequently face financial exploitation and unnecessary clinical interventions. Therefore, the government recognized that immediate legislative and administrative intervention is necessary to protect vulnerable couples. Indeed, these disturbing incidents underscore the urgent need for a more robust oversight mechanism. Clinicians must now prepare for a much stricter scrutiny of their daily operations. Ultimately, the upcoming reforms will redefine operational standards for all fertility clinics in India.

Mandate of the Justice Asha Menon Committee

To tackle these complex challenges, the NCW constituted a high-level multidisciplinary committee. Specifically, retired Delhi High Court Judge Justice Asha Menon will chair this expert panel. The committee brings together leading experts from diverse fields, including the judiciary, forensic science, and medicine. Additionally, specialists in gynaecology, public policy, law enforcement, and the Health Ministry will participate actively. This diverse composition ensures a comprehensive examination of all legal, ethical, and clinical dimensions of assisted reproduction. Primarily, the committee will evaluate the implementation of the Assisted Reproductive Technology (Regulation) Act, 2021. It will also review the Surrogacy (Regulation) Act, 2021, and the subsequent 2026 amendment rules. During this review, the panel will identify procedural gaps that currently enable fraudulent practices and exploitation. Subsequently, the experts will propose robust legal and policy reforms to strengthen institutional accountability. They will also focus heavily on improving the safety of women during clinical procedures. Ultimately, their recommendations will reshape the regulatory landscape and establish a more transparent ecosystem. Furthermore, the panel will establish state-level mechanisms to monitor operational compliance and protect overall patient interests.

Addressing Medical Tourism and Sex Selection

The rapid rise of medical tourism in the fertility sector presents unique regulatory challenges for India. Many foreign nationals travel to Indian clinics to seek affordable and advanced reproductive treatments. However, this growing trend has raised serious concerns about the possible circumvention of local legal safeguards. Specifically, authorities worry about the illegal practice of sex selection under the guise of routine fertility therapies. Therefore, the expert committee will examine current practices to prevent any violations of the PC-PNDT Act. Additionally, the panel will review the commercial aspects of international fertility agreements. This step is crucial to prevent the financial exploitation of vulnerable surrogate mothers and egg donors. Moreover, the committee aims to restrict unauthorized medical access by reinforcing biological traceability guidelines. Clinicians must subsequently maintain meticulous records of all foreign patients and donor gametes. In doing so, they will ensure complete transparency and prevent illegal trafficking of biological materials. Ultimately, these measures will safeguard India's reputation as an ethical and highly compliant hub for international fertility care. Consequently, healthcare providers must align their practices with these national ethical standards. This alignment will ensure seamless operations.

The Role of Consent in IVF Clinic Regulation

Patient consent and privacy remain the cornerstones of ethical medical practice, especially in assisted reproduction. Currently, the lack of uniform treatment protocols across Indian states creates significant clinical inconsistencies. For instance, some clinics perform unnecessary procedures simply to increase profit margins. Consequently, patients face both severe financial exploitation and avoidable health risks during their fertility journeys. To counter this, the new expert committee will propose standard operating procedures for all registered centres. These guidelines will establish strict protocols for obtaining informed consent, ensuring patients fully understand all potential risks. Furthermore, the panel will strengthen data privacy measures to protect sensitive genetic and medical records. In addition, they will mandate robust biological traceability systems to prevent mix-ups and biological errors. Clinicians must actively adopt these clinical standards to ensure high-quality patient care. Indeed, maintaining absolute transparency in donor matching and embryo transfer is non-negotiable under the revised rules. Therefore, healthcare providers must systematically document every clinical stage to remain fully compliant with the evolving laws. Ultimately, these standardized patient consent protocols will elevate reproductive healthcare standards across the nation.

Implications for Fertility Specialists in India

The upcoming legal reforms will significantly impact gynecologists, embryologists, and fertility specialists across the country. Initially, some practitioners may find the new documentation and reporting guidelines quite demanding. However, these regulations will ultimately protect clinics from legal liabilities and false malpractice claims. In addition, standardized protocols will streamline laboratory operations and reduce clinical errors during embryo handling. To adapt successfully, specialists must regularly audit their internal procedures and update patient consent templates. Additionally, they should conduct continuous training sessions for their laboratory staff on biological traceability. Subsequently, this proactive approach will ensure seamless compliance when state authorities conduct unexpected clinical inspections. Furthermore, clinics must actively collaborate with local registries to maintain accurate real-time data. In doing so, practitioners will demonstrate their commitment to ethical healthcare delivery and patient safety. Indeed, the transition toward a highly regulated fertility sector represents a positive step forward. Ultimately, this collaborative effort will establish a secure clinical environment that respects and protects women's reproductive rights. Consequently, fertility specialists who implement these ethical practices will build stronger reputations and attract more patients seeking safe care.

Frequently Asked Questions

Q1: Why did the National Commission for Women form this expert committee?

The National Commission for Women constituted this panel because of rising concerns about clinical irregularities. Specifically, a high-profile baby mix-up in Gurugram recently exposed critical flaws in biological traceability. Consequently, existing laws like the ART Act require a comprehensive review to prevent fraudulent practices. Therefore, this committee will recommend robust safeguards to protect the dignity and safety of women undergoing fertility treatments.

Q2: What specific laws will the expert committee review?

The expert panel will review the implementation of the Assisted Reproductive Technology (Regulation) Act, 2021. Additionally, it will evaluate the Surrogacy (Regulation) Act, 2021, alongside the latest amendment rules enacted in 2026. Through this process, the committee aims to identify existing legal loopholes and propose robust reforms. Consequently, these changes will establish much stricter compliance guidelines and improve transparency nationwide.

Q3: How will the committee's recommendations protect patient rights?

The committee will propose comprehensive Standard Operating Procedures to standardize clinical protocols and treatment standards across states. In addition, these new guidelines will reinforce strict patient consent and biological traceability systems. As a result, patients will enjoy better protection against unnecessary medical procedures and unexpected financial exploitation. Ultimately, these measures will guarantee that ethical care remains a priority at every stage of treatment.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. IVF clinics under scanner: NCW forms expert panel for review of regulatoryframework, laws - ETHealthworld


2. IVF clinics in the dock: NCW sets up expert panel to review laws, compliance - The Tribune


3. Women's panel sets up expert committee for IVF sector after Gurugram baby mix-up - India Today